Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magdalena Płonka

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Open Access Macedonian Journal of Medical Sciences|August 14, 2019
Evaluation of Pregnancy Outcomes at Advanced Maternal AgeMałgorzata Radoń-Pokracka, Beata Adrianowicz, Magdalena Płonka, et al.
Folia Medica Cracoviensia|January 7, 2020
Labor induction at full-term and post-term pregnanciesAnna Modrzyńska, Małgorzata Radoń-Pokracka, Magdalena Płonka, et al.
Leukemia|December 21, 2023
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinibKaterina Machova Polakova, Ali Albeer, Vaclava Polivkova, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Open Access Macedonian Journal of Medical Sciences|August 14, 2019
Evaluation of Pregnancy Outcomes at Advanced Maternal AgeMałgorzata Radoń-Pokracka, Beata Adrianowicz, Magdalena Płonka, et al.
Folia Medica Cracoviensia|January 7, 2020
Labor induction at full-term and post-term pregnanciesAnna Modrzyńska, Małgorzata Radoń-Pokracka, Magdalena Płonka, et al.
Leukemia|December 21, 2023
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinibKaterina Machova Polakova, Ali Albeer, Vaclava Polivkova, et al.
Pageof 1